Your browser doesn't support javascript.
loading
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial.
Versteijne, Eva; Suker, Mustafa; Groothuis, Karin; Akkermans-Vogelaar, Janine M; Besselink, Marc G; Bonsing, Bert A; Buijsen, Jeroen; Busch, Olivier R; Creemers, Geert-Jan M; van Dam, Ronald M; Eskens, Ferry A L M; Festen, Sebastiaan; de Groot, Jan Willem B; Groot Koerkamp, Bas; de Hingh, Ignace H; Homs, Marjolein Y V; van Hooft, Jeanin E; Kerver, Emile D; Luelmo, Saskia A C; Neelis, Karen J; Nuyttens, Joost; Paardekooper, Gabriel M R M; Patijn, Gijs A; van der Sangen, Maurice J C; de Vos-Geelen, Judith; Wilmink, Johanna W; Zwinderman, Aeilko H; Punt, Cornelis J; van Eijck, Casper H; van Tienhoven, Geertjan.
Afiliación
  • Versteijne E; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Suker M; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Groothuis K; Clinical Research Department, Comprehensive Cancer Organisation the Netherlands (IKNL), Nijmegen, the Netherlands.
  • Akkermans-Vogelaar JM; Clinical Research Department, Comprehensive Cancer Organisation the Netherlands (IKNL), Nijmegen, the Netherlands.
  • Besselink MG; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Bonsing BA; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  • Buijsen J; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Busch OR; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Creemers GM; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.
  • van Dam RM; Department of Surgery, Division of Hepato-Pancreato-Biliary & Oncology, European Surgery Center Aachen Maastricht, Maastricht UMC+, Maastricht, the Netherlands.
  • Eskens FALM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Festen S; Department of Surgery, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.
  • de Groot JWB; Department of Medical Oncology, Isala Oncology Centre, Zwolle, the Netherlands.
  • Groot Koerkamp B; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • de Hingh IH; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
  • Homs MYV; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • van Hooft JE; Department of Gastroenterology and Hepatology, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Kerver ED; Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.
  • Luelmo SAC; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Neelis KJ; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands.
  • Nuyttens J; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Paardekooper GMRM; Department of Radiation Oncology, Isala Oncology Center, Zwolle, the Netherlands.
  • Patijn GA; Department of Surgery, Isala Oncology Center, Zwolle, the Netherlands.
  • van der Sangen MJC; Department of Radiation Oncology, Catharina Hospital, Eindhoven, the Netherlands.
  • de Vos-Geelen J; Department of Internal Medicine, Division of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht UMC+, Maastricht, the Netherlands.
  • Wilmink JW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Zwinderman AH; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Punt CJ; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • van Eijck CH; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • van Tienhoven G; Department of Radiation Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
J Clin Oncol ; 38(16): 1763-1773, 2020 06 01.
Article en En | MEDLINE | ID: mdl-32105518
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pancreatectomía / Neoplasias Pancreáticas / Pancreaticoduodenectomía / Fraccionamiento de la Dosis de Radiación / Terapia Neoadyuvante / Carcinoma Ductal Pancreático / Desoxicitidina / Quimioradioterapia Adyuvante / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pancreatectomía / Neoplasias Pancreáticas / Pancreaticoduodenectomía / Fraccionamiento de la Dosis de Radiación / Terapia Neoadyuvante / Carcinoma Ductal Pancreático / Desoxicitidina / Quimioradioterapia Adyuvante / Antimetabolitos Antineoplásicos Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: J Clin Oncol Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos